References
- Bravo, A. A., Sheth, S. G., Chopra, S. (2001). Liver biopsy. New Engl. J. Med., 344, 495–500.
- Hettmansperger, T. P., McKean, J. W. (2011). Robust Nonparametric Statistical Methods. 2nd ed., New York, Chapman-Hall. 554 pp.
- Kaspar, M. B., Sterling, R. K. (2017). Mechanisms of liver disease in patients infected with HIV. BMJ Open Gastro, 4, e000166.
- Kim H. N., Nance, R., Rompaey, S. V., Delaney, J. C., Crane, H. M., Cachay, E. R., Geng, E., Boswell, S. L., Rodriguez, B., Eron, J., Saag, M., Moore, R. D., Kitahata, M. M. (2016). Poorly controlled HIV infection: An independent risk factor for liver fibrosis. J. Acquir. Immune Defic. Syndr., 72 (4), 437–443.
- Kloke, J. D., McKean, J. W. (2012). Rfit: Rank-based estimation for linear models rank-regression. The R. Journal, 4 (2), 57–64.
- Konerman, M. A., Mehta, S. H., Sutcliffe, C. G., Vu, T., Higgins, Y., Torbenson, M. S., Moore, R. D., Thomas, D. L., Sulkowski, M. S. (2014). Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: Prospective analysis of 435 liver biopsy pairs. Hepatol. Baltim. Md., 59, 767–775.
- Larrousse, M., Laguno, M., Segarra, M., De Lazzari, E., Martinez, E., Luis Blanco, J. L., León, A., Deulofeu, R., Miquel, R., Milinkovic, A., Lonca, M., Miró, J. M., Biglia, A., Murillas, J., Gatell, J. M., Mallolas, J. (2007). Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients. J. Acquir. Immune Defic. Syndr., 46, 304–311.
- Neuman, M. G., Cohen, L. B., Nanaua R. M. (2016). Hyaluronic acid as a non-invasive biomarker of liver fibrosis. Clin. Biochem., 49, 302–315.
- Peters, L., Neuhaus, J., Mocroft, A., Soriano, V., Rockstroh, J., Dore, G., Puoti, M., Tedaldi, E., Clotet, B., Kupfer, B., Lundgren, J. D., Klein, M. B., for the INSIGHT SMART Study Group. (2011). Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study. Antivir. Ther.16 (5), 667–675.
- Qurishi, N., Kreuzberg, C., Lüchters, G., Effenberger, W., Kupfer, B., Sauerbruch, T., Rockstroh, J. K., Spengler, U. (2003). Effect of anti-retroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet, 362, 1708–1713.
- Schmid, P., Bregenzer, A., Huber, M., Rauch, A., Jochum, W., Müllhaupt, B., Vernazza, P., Opravil, M., Weber, R., Swiss HIV Cohort Study. (2015). Progression of liver fibrosis in HIV/HCV co-infection: A comparison between non-invasive assessment methods and liver biopsy. PLoS ONE, 10 (9), e0138838.
- Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Cassia, M., Correa, M.C., Montaner, J., Sulkowski, M. S., Torriani, F. J., Dieterich, D. T., Thomas, D. L., Messinger, D., Nelson, M. for the APRICOT Clinical Investigators. (2006). Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatol. Baltim. Md, 43, 1317–1325.